Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults With Asthma
Status:
Completed
Trial end date:
2018-06-28
Target enrollment:
Participant gender:
Summary
Phase 1, 3-part study to assess safety, tolerability and PK of single and multiple doses of
itraconazole administered as a dry powder for inhalation (PUR1900) in healthy subjects (parts
1 and 2) and a 2-period crossover study of single doses of itraconazole administered as a dry
powder for inhalation (PUR1900) and an oral solution (Sporanox) in adults with mild to
moderate, stable asthma (part 3)